AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says
AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says Reuters
Read the full story on Reuters → Opens the original article on news.google.comSummary aggregated from Reuters's public RSS feed. The full reporting belongs to Reuters — please read it on their site.